Recent developments include strategic investments, product launches, technology integrations, and capital raises that reflect Gaxos.AI's active growth and expansion efforts.

• In March 2026, Gaxos.AI acquired a 19.99% membership interest in America First Defense.AI LLC for $2.9 million [N1][S1].
• In May 2025, the company launched UnGPT.ai, a tool to transform AI-generated text into human-quality content [N2].
• In March 2025, Gaxos.AI acquired advanced AI technology to enhance content creation services [N3].
• In December 2024, Gaxos.AI announced and priced a $4 million registered direct offering and concurrent private placement of common stock and warrants [N4][N5][N6].
• In December 2024, Gaxos.AI integrated Meshy 4 into Gaxos Labs to enhance 3D modeling for game developers [N7].
• In December 2024, the company filed a $50 million mixed securities shelf registration [N8].

Gaxos.AI has demonstrated the ability to launch innovative AI products across multiple sectors, including gaming, health, and digital content creation, supported by strategic acquisitions and partnerships. Its strong liquidity position as of Q1 2026 provides a financial foundation to continue product development and market expansion. The company's integration of advanced AI technologies and proprietary enhancements positions it to address growing demand for AI-driven personalization and content generation. The diversified product portfolio and recent capital raises may enable Gaxos to capture emerging opportunities in AI applications and digital ecosystems.

Gaxos.AI operates in highly competitive and rapidly evolving markets where larger companies with more resources may outpace its growth and innovation. The company has a limited operating history, has not yet achieved sustainable profitability, and continues to incur losses. Its small core team and reliance on external consultants may limit operational scalability. Regulatory compliance, especially in healthcare and data privacy, presents ongoing challenges. Failure to manage growth effectively or secure additional financing could adversely impact its business and financial condition.

Gaxos.AI's moat is based on its diversified portfolio of AI-powered solutions tailored to niche and emerging markets such as AI-enabled gaming, personalized health optimization, and digital faith platforms. The company leverages proprietary technology combined with integrations of leading third-party AI models and maintains intellectual property protections through patents, copyrights, and trade secrets. Its early mover advantage in combining AI with gaming and NFT ecosystems, along with strategic partnerships and acquisitions, supports differentiation. However, the company faces intense competition from larger, established players with greater resources, and its limited operating history and small team may constrain its ability to scale rapidly.

• Limited Operating History and Financial Losses: Gaxos.AI has a limited operating history and has not generated sustainable revenue since inception, incurring significant losses as it invests in product development and market expansion [S1].
• Competitive Market Environment: The company faces intense competition in AI applications, gaming, health and wellness, and supplements from larger, established companies with greater resources and brand recognition [S1].
• Regulatory and Compliance Risks: Gaxos is subject to various data privacy laws and healthcare regulations including HIPAA, and must maintain compliance to avoid legal and reputational risks [S1].
• Dependence on Key Personnel and External Consultants: With only three full-time employees as of March 2026, the company relies heavily on key management and external consultants, posing risks to continuity and execution [S1].
• Need for Additional Financing: The company requires additional financing to support operations and growth initiatives; inability to secure funding on acceptable terms could restrict business operations [S1].

• Gaxos.AI Inc. is a technology company focused on AI-powered solutions across defense, health and wellness, entertainment, and productivity sectors [S1].
• The company operates several business segments including Gaxos Labs (AI applications product studio), Gaxos Health (AI-powered health optimization), RNK Health (health-related products marketing), and Gaxos Gaming (AI-enabled gaming platform) [S1].
• Gaxos Labs launched in September 2024 with generative AI services for game developers, featuring AI-powered creativity tools, monetization options, and integration with Unity and Godot engines [S1].
• In May 2025, Gaxos launched UnGPT.ai, a tool enhancing AI-generated text to sound more natural and human-like using a proprietary multi-pass transformation model [S1][N2].
• In August 2025, the company launched Art-Gen.AI, an AI image and video creation platform combining models from Google, Stability AI, and PixVerse with proprietary enhancements [S1][N22].
• In December 2025, Gaxos launched Bible Pray AI, an AI-powered spiritual growth platform targeting digital faith and personal development markets [S1].
• Gaxos Health develops AI-driven personalized wellness strategies integrating biometric data and health goals, launched its AI-powered health optimization product in Q3 2024 [S1][N4].
• RNK Health LLC, a wholly-owned subsidiary formed in September 2024, markets health-related products including medications and supplements, with a 70% ownership by Gaxos [S1].
• Gaxos Gaming offers proprietary games with AI personalization and NFT minting capabilities; as of December 31, 2025, five games have been launched including Space Striker AI and Brawl Bots [S1].
• The company acquired a 19.99% membership interest in America First Defense.AI LLC for $2.9 million in March 2026 [S1][N1].
• Gaxos has made multiple capital raises including registered direct offerings totaling $4 million in December 2024 and filed a $50 million mixed securities shelf in December 2024 [N4][N5][N6][N8].
• The company integrates third-party AI technologies such as Meshy 4 and Recraft AI into Gaxos Labs to enhance 3D modeling and AI solutions for game developers [N7].
• Gaxos announced a visual editor for the Godot Engine and integrated Suno AI and ElevanLabs into Gaxos Labs to enhance AI capabilities [N7].
• The board approved Bitcoin as a treasury reserve asset in November 2024 [N7].
• As of March 31, 2026, Gaxos reported cash and equivalents of $1.51 million, current assets of $12.16 million, current liabilities of $0.57 million, and a strong current ratio of 21.35, indicating strong liquidity [S2].
• Revenue for the quarter ended March 31, 2026 was $1.81 million, with a net loss of $2.17 million and basic and diluted EPS of -$0.25 per share [S2].
• The company has a limited operating history, a small number of full-time employees (3 as of March 15, 2026), and outsources many R&D and operational tasks to external consultants [S1].
• Gaxos faces intense competition in AI applications, gaming, health and wellness, and supplements markets from larger and established companies [S1].
• The company is subject to various data privacy laws and healthcare regulations including HIPAA, and takes measures to protect personal information of users [S1].
• Gaxos has not generated sustainable revenue since inception and continues to incur losses as it invests in product development and market expansion [S1].
• The company relies on key personnel and external consultants, and faces risks related to managing growth, regulatory compliance, and competition [S1].